Rogel, A., Ibrahim, F. M., Thirdborough, S. M., Renart-Depontieu, F., Birts, C. N., Buchan, S. L., Preville, X., King, E. V. and Al-Shamkhani, A., 2022. Fc-γ receptor-mediated crosslinking co-defines the immunostimulatory activity of anti-human CD96 antibodies. JCI Insight, 7 (19), e158444.
Full text available as:
|
PDF (OPEN ACCESS ARTICLE)
158444.2-20220926101445-covered-e0fd13ba177f913fd3156f593ead4cfd.pdf - Published Version Available under License Creative Commons Attribution. 1MB | |
PDF (OPEN ACCESS ARTICLE)
Final CD96 paper.pdf - Published Version Restricted to Repository staff only Available under License Creative Commons Attribution. 2MB | ||
Copyright to original material in this document is with the original owner(s). Access to this content through BURO is granted on condition that you use it only for research, scholarly or other non-commercial purposes. If you wish to use it for any other purposes, you must contact BU via BURO@bournemouth.ac.uk. Any third party copyright material in this document remains the property of its respective owner(s). BU grants no licence for further use of that third party material. |
DOI: 10.1172/jci.insight.158444
Abstract
New strategies that augment T-cell responses are required to broaden the therapeutic arsenal against cancer. CD96, TIGIT and CD226 are receptors that bind to a communal ligand, CD155, and transduce either inhibitory or activating signals. Whereas the function of TIGIT and CD226 is established, the role of CD96 remains ambiguous. Using a panel of engineered antibodies, we discovered that the T-cell stimulatory activity of anti-CD96 antibodies requires antibody crosslinking and is potentiated by Fc-gamma receptors. Thus, soluble 'Fc silent' anti-CD96 antibodies failed to stimulate human T cells, whereas the same antibodies were stimulatory after coating onto plastic surfaces. Remarkably, the activity of soluble anti-CD96 antibodies was reinstated by engineering the Fc domain to a human IgG1 isotype and was dependent on antibody trans-crosslinking by Fc-γRI. In contrast, neither human IgG2 nor variants with increased Fc-γ receptor IIB binding possessed stimulatory activity. Anti-CD96 antibodies acted directly on T cells and augmented gene expression networks associated with T-cell activation, leading to proliferation, cytokine secretion and resistance to regulatory T-cell suppression. Furthermore, CD96 expression correlated with survival in HPV+ head and neck squamous cell carcinoma and its crosslinking activated tumor-infiltrating T cells, thus highlighting the potential of anti-CD96 antibodies in cancer immunotherapy. .
Item Type: | Article |
---|---|
ISSN: | 2379-3708 |
Uncontrolled Keywords: | Cancer immunotherapy; Costimulation; Immunology; T cells |
Group: | Faculty of Science & Technology |
ID Code: | 37427 |
Deposited By: | Symplectic RT2 |
Deposited On: | 05 Sep 2022 10:05 |
Last Modified: | 24 Jan 2023 10:01 |
Downloads
Downloads per month over past year
Repository Staff Only - |